GLP-1 Weight Loss Medications in Las Vegas
You can get GLP-1 weight loss medication in Las Vegas through a physician evaluation at LiveNow Longevity — a board-certified MD prescribes semaglutide or tirzepatide after labs, and the medication is dispensed by a licensed US pharmacy at pass-through cost with no markup. The $88 evaluation is the first step.
Medically reviewed by Charles Kamen, MD, board-certified neurologist ·
GLP-1 medications are among the most effective tools available for weight management, and they work best inside an actual medical program: baseline labs, individualized titration, a nutrition and muscle-preservation strategy, and a physician who follows your progress. LiveNow Longevity is a physician practice, not a med spa — Dr. Charles Kamen, MD evaluates you first and prescribes only when appropriate.
“GLP-1” is a class, not a single drug. The two prescription options available in Las Vegas today are semaglutide (a GLP-1 receptor agonist) and tirzepatide (a dual GLP-1/GIP agonist). A newer triple-agonist, retatrutide, is still investigational and cannot be prescribed. If you want the physician-led weight-management program these medications sit inside, see medical weight loss in Las Vegas.
This page is about getting physician-prescribed GLP-1 care locally. For a purely educational, drug-by-drug breakdown of the class, see our GLP-1 medication comparison. Care is available in person at Eastern Avenue and the 215 in southeast Las Vegas, or by secure telehealth anywhere in Nevada.
What is a GLP-1 (and GIP/glucagon) medication?
GLP-1 (glucagon-like peptide-1) is a hormone your gut releases after eating. It signals fullness to the brain, slows how quickly the stomach empties, and helps regulate blood sugar. GLP-1 receptor agonists are medications that mimic this hormone, which is why they reduce appetite and support weight management. Newer medications add a second or third receptor: tirzepatide also activates GIP, and the investigational retatrutide adds glucagon — each an attempt to build on the GLP-1 effect. These are prescription medications used alongside nutrition and activity changes, not a substitute for them.
GLP-1 Medications Compared
| Medication | Receptor targets | FDA status | Available now? |
|---|---|---|---|
| Semaglutide | GLP-1 | FDA-approved | Yes — after evaluation |
| Tirzepatide | GLP-1 + GIP | FDA-approved | Yes — after evaluation |
| Retatrutide | GLP-1 + GIP + glucagon | Investigational (not approved) | No — ask Dr. Kamen |
What the Trials Showed
The GLP-1 evidence base includes large randomized NEJM trials. These are trial averages from those studies, not individual guarantees — results vary widely, and every number below comes from a highest-studied dose used alongside lifestyle changes.
| Medication (trial) | Average result | Context |
|---|---|---|
| Semaglutide (STEP 1) | ~14.9% average weight loss at 68 weeks | Randomized, placebo-controlled, obesity without diabetes |
| Tirzepatide (SURMOUNT-1) | ~20.9% average weight loss at 72 weeks | Highest studied dose, obesity without diabetes |
| Retatrutide (Phase 2) | ~28% average weight loss at 48 weeks, highest dose (investigational) | Not FDA-approved; not available to prescribe |
Semaglutide also has a cardiovascular-outcomes benefit: in the SELECT trial it reduced the risk of major cardiovascular events in people with overweight or obesity and existing heart disease. Individual results vary widely and are not guaranteed.
Are GLP-1 Medications FDA-Approved?
Current as of July 2026: semaglutide and tirzepatide are FDA-approved (semaglutide as Wegovy® and Ozempic®; tirzepatide as Zepbound® and Mounjaro®), all verifiable in the FDA drug database. Retatrutideis investigational and not FDA-approved, so it cannot be prescribed. Compounded versions of semaglutide and tirzepatide also exist, produced by licensed 503A/503B compounding pharmacies under a physician’s prescription — these are not FDA-approved finished products and are a different category from the brand-name medications. We use FDA-approved GLP-1 medication when appropriate for your plan.
How to get GLP-1 care in Las Vegas: 3 steps
GLP-1 medications are prescription-only in Nevada, so care always starts with a physician. At LiveNow Longevity the path is the same for everyone, and the pricing is transparent:
| Step | What happens | Cost |
|---|---|---|
| 1. Medical evaluation | Board-certified MD reviews your history, goals, and orders baseline labs (metabolic panel, A1C, thyroid as indicated). | $88, applied toward your plan |
| 2. Prescription, if appropriate | If a GLP-1 such as semaglutide or tirzepatide is clinically appropriate, Dr. Kamen prescribes it and it is dispensed by a licensed US pharmacy. | Pharmacy pass-through cost, no markup |
| 3. Monitored follow-up | Scheduled physician follow-ups manage tolerability and progress — in person at Eastern Ave and the 215, or by telehealth for Nevada residents. | Included in your plan |
Be cautious of “research chemical” or gray-market vendors advertising GLP-1 medication online without a prescription — these products are not manufactured, tested, or labeled for human use, and we strongly recommend against them.
GLP-1 Weight Loss in Las Vegas — FAQ
Where can I get GLP-1 medication in Las Vegas?
You can get physician-prescribed GLP-1 medication in Las Vegas at LiveNow Longevity. Care starts with an $88 evaluation by board-certified neurologist Dr. Charles Kamen, MD, covering history, labs, and goals. If a GLP-1 such as semaglutide or a GLP-1/GIP agent such as tirzepatide is clinically appropriate, it is prescribed and dispensed through a licensed US pharmacy.
How much does GLP-1 treatment cost in Las Vegas?
At LiveNow Longevity, you start with an $88 physician evaluation that is applied toward your plan if you continue. Medication is then billed at pass-through cost with no markup; your exact monthly cost depends on the medication, dose, and pharmacy, and is reviewed with you in person before you commit to anything.
What is a GLP-1 medication?
A GLP-1 medication is a drug that activates the GLP-1 receptor, part of the body's natural appetite and blood-sugar signaling. This class includes semaglutide (GLP-1) and tirzepatide (which activates both GLP-1 and GIP). They are used, alongside nutrition and activity changes, to support weight management and, in some cases, blood-sugar control.
Which GLP-1 medication is best for me?
The right choice depends on your history, labs, tolerability, and goals — there is no single best option for everyone. Semaglutide activates the GLP-1 receptor; tirzepatide activates both GLP-1 and GIP. The evaluation determines which one, if either, fits you, and our physician-reviewed comparison walks through the evidence.
Is GLP-1 the same as semaglutide or Ozempic?
Semaglutide is one GLP-1 medication, sold as FDA-approved Ozempic® (type 2 diabetes) and Wegovy® (weight management). "GLP-1" is the broader class, which also includes tirzepatide (a dual GLP-1/GIP agent). So semaglutide is a GLP-1, but not every GLP-1 is semaglutide.
Do you offer GLP-1 care by telehealth in Nevada?
Yes. Nevada residents can complete the evaluation and follow-ups by secure telehealth, with labs drawn near you. In-person care is available at our southeast Las Vegas clinic at Eastern Avenue and the 215.
What are common GLP-1 side effects?
The most common GLP-1 side effects are nausea, constipation, fatigue, and GI discomfort, especially during dose increases. Physician-managed titration, a nutrition strategy, and scheduled follow-ups exist precisely to manage this, and to catch the situations where the medication should be adjusted or stopped.
Do I need labs before starting a GLP-1?
Yes. At LiveNow Longevity, baseline labs (a metabolic panel, A1C, thyroid, and more as indicated) are drawn before any GLP-1 prescription is written. Dr. Kamen reviews them to decide whether a GLP-1 is appropriate and safe for you, rather than guessing from a questionnaire.
Can I get retatrutide in Las Vegas?
No. Retatrutide is an investigational triple-receptor agonist (GLP-1 + GIP + glucagon) still in clinical trials, and it is not FDA-approved — so no clinic can prescribe it as a standard prescription. Semaglutide and tirzepatide are FDA-approved and available today after an evaluation. Dr. Kamen can walk you through the current retatrutide research at your visit.
Does GLP-1 help with more than weight?
Some GLP-1 medications have benefits beyond weight. In the SELECT trial, semaglutide reduced the risk of major cardiovascular events in adults with overweight or obesity and existing cardiovascular disease, and GLP-1 medications are also used in type 2 diabetes. Whether any of this applies to you is a medical decision made after reviewing your full history and labs.
Selected Research
- Wilding JPH, et al. N Engl J Med. 2021;384(11):989-1002. (STEP 1: Once-Weekly Semaglutide in Adults with Overweight or Obesity).
- Jastreboff AM, et al. N Engl J Med. 2022;387(3):205-216. (SURMOUNT-1: Tirzepatide Once Weekly for the Treatment of Obesity).
- Lincoff AM, et al. N Engl J Med. 2023;389(24):2221-2232. (SELECT: Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes).
- Müller TD, et al. Mol Metab. 2019;30:72-130. (Glucagon-like peptide 1 (GLP-1) — mechanism and therapeutics review).
Trial-result sources only. Not a treatment claim or a guarantee. Individual results vary, and appropriateness is determined by a licensed physician after evaluation.
Physician-Led in Las Vegas
Find out which GLP-1 is right for you
Schedule the $88 evaluation. After your labs and review, Dr. Kamen discusses an individualized plan and its costs, including whether semaglutide or tirzepatide fits you better.
Ready to start your longevity care?
Book your $88 evaluation with Dr. Kamen today, online, by phone, or by text.
Prefer to talk? Call (702) 808-2650 or text us to book.
Also serving Henderson — or explore semaglutide weight loss in Las Vegas.